How many international patents are there in Hengrui Pharma?

According to the semi-annual financial report released by the company, Hengrui Pharma spent 25,865,438+million yuan on R&D in the first half of the year, up 38.48% year-on-year, and R&D investment accounted for 65,438+09,454,38+0% of sales revenue, a record high. Driven by the huge investment of R&D, the company achieved fruitful results in the first half of the year.

In the first half of the year, Hengrui Pharma * * obtained 5 approval documents for the production of innovative pharmaceutical preparations and 9 approval documents for the production of generic drugs, 4 1 approval documents for drug clinical application and1approval documents for variety consistency evaluation, completed the declaration for consistency evaluation of the two products, and carried out more than 240 clinical projects at home and abroad, with a considerable research and development stock. At the same time, we submitted new domestic patent applications 13 1 piece, 39 new international PCT applications, 64 domestic patents and 59 foreign patents.